Drug combo for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new combination of two drugs (HRS2398 and Adebrelimab) for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this combination can help shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have advanced cancer that has not responded to standard treatments, or there is no standard treatment available.
- You have previously received immunotherapy and a platinum-based chemotherapy for cancer that has spread or come back.
- You have at least one tumor that can be measured on scans.
- You are in good enough physical shape to be up and about (ECOG score 0-1).
- You do not have an active autoimmune disease, uncontrolled brain metastases, or fluid buildup in the belly or chest that needs draining.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination treatment called HS-20089 for people with advanced solid tumors. The goal is to see if it is safe and how well it works against cancer that has not responded to other treatments.
This study is testing an investigational drug called SG1827, either alone or combined with other standard immunotherapy medicines, for advanced solid tumors. The goal is to see if this combination can help shrink or slow the growth of the tumor.
This trial tests a new drug, SHR-1826, combined with other cancer treatments for people with advanced solid tumors that have not responded to prior therapy. The goal is to see if the combination is safe and effective.
This trial tests a new drug, HRS-4642, combined with other cancer treatments for people with advanced solid tumors. It looks at how well the combination works and if it is safe for you.
This trial tests a new drug called HRS-6768 for people with advanced solid tumors that have stopped responding to standard treatments or have no good options. It aims to see if the drug is safe and effective.
This trial tests two drugs, HRS-4642 and SHR-A2102, for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if this combination can help shrink or slow tumor growth.
Hear when a new Advanced Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.